News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioElectronics Corporation' Topical Pain Therapy Now Available Throughout Europe


8/21/2012 12:05:39 PM

FREDERICK, Md., Aug. 21, 2012 /PRNewswire/ -- BioElectronics Corporation (BIEL), maker of patented, inexpensive, disposable pain management devices, said today that ActiPatch® Musculoskeletal Pain Therapy is now available for purchase on Amazon.co.uk in 27 European countries. Visit www.actipatchrelief.co.uk to place an order in Europe.

"ActiPatch® has five times better pain relief and is 100% safer than over-the-counter drugs. The most commonly used OTC drugs have a significant number of side effects, are minimally effective and have only short-term relief. ActiPatch, which retails for 14.99 to 19.99 for 90 8-hour treatments or under .25 each, is the sound utilization of advanced technology to lower the cost of healthcare and to provide sustained pain relief," said Andrew Whelan, President.

The countries covered in the sales and distribution agreement are the United Kingdom, Germany, France, Spain, Italy, Belgium, Luxembourg, Netherlands, Ireland, Portugal, Austria, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Greece, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia, Slovenia and Sweden.

About BioElectronics Corporation
BioElectronics is an award winning developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal ailments, the Allay Menstrual Cycle Pain Therapy, and RecoveryRx for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care to reduce soft tissue pain and accelerate healing. For more information, please visit www.BielCorp.com.

Contact:

Paul Knopick
940.262.3584
pknopick@eandecommunications.com

SOURCE BioElectronics Corporation


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES